Found 6 matching trials
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
PHASE2Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM A...
Location
University of Alabama at Birmingham
A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors
PHASE2Researchers are looking for a better way to treat people with solid tumors....
Location
City of Hope - Duarte Cancer Center
Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers
PHASE2In recent years, anti-angiogenic agents have been incorporated into clinica...
Location
The Moncton Hospital (Horizon Health Network)
Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers
PHASE2REFIT-MSS is a non-randomized, multicenter, open-label, multi-cohort, 2-sta...
Location
Multiple Locations
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
PHASE1FaR-RMS is an over-arching study for children and adults with newly diagnos...
Location
Queensland Children's Hospital
Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer
PHASE2This is a multicenter, single-arm, phase II study of nivolumab in combinati...
Status
Active Not Recruiting
Location
Institut Jules Bordet